Integer Holdings Co. (NYSE:ITGR) Shares Sold by Royal Bank of Canada

Royal Bank of Canada reduced its position in Integer Holdings Co. (NYSE:ITGR - Free Report) by 2.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 471,865 shares of the medical equipment provider's stock after selling 9,805 shares during the period. Royal Bank of Canada owned about 1.41% of Integer worth $62,533,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in ITGR. Blue Trust Inc. increased its position in shares of Integer by 4.4% during the fourth quarter. Blue Trust Inc. now owns 1,689 shares of the medical equipment provider's stock worth $220,000 after purchasing an additional 71 shares in the last quarter. Arizona State Retirement System boosted its position in Integer by 0.9% during the fourth quarter. Arizona State Retirement System now owns 9,732 shares of the medical equipment provider's stock worth $1,290,000 after acquiring an additional 84 shares during the last quarter. HighPoint Advisor Group LLC boosted its position in Integer by 6.4% during the fourth quarter. HighPoint Advisor Group LLC now owns 1,684 shares of the medical equipment provider's stock worth $234,000 after acquiring an additional 101 shares during the last quarter. Norden Group LLC grew its stake in Integer by 7.0% during the 4th quarter. Norden Group LLC now owns 1,668 shares of the medical equipment provider's stock valued at $221,000 after acquiring an additional 109 shares in the last quarter. Finally, Corient Private Wealth LLC raised its holdings in Integer by 6.4% in the 4th quarter. Corient Private Wealth LLC now owns 1,969 shares of the medical equipment provider's stock valued at $261,000 after acquiring an additional 118 shares during the last quarter. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Integer Stock Up 0.2%

Shares of ITGR traded up $0.27 during midday trading on Monday, hitting $118.43. The company had a trading volume of 244,616 shares, compared to its average volume of 372,916. Integer Holdings Co. has a 1 year low of $104.93 and a 1 year high of $146.36. The firm has a market capitalization of $4.13 billion, a P/E ratio of 35.25, a P/E/G ratio of 1.72 and a beta of 1.03. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.09 and a current ratio of 2.95. The company's 50-day simple moving average is $118.40 and its 200-day simple moving average is $129.13.

Integer (NYSE:ITGR - Get Free Report) last issued its earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share for the quarter, beating the consensus estimate of $1.27 by $0.04. Integer had a net margin of 6.92% and a return on equity of 11.65%. The firm had revenue of $437.39 million for the quarter, compared to analysts' expectations of $428.51 million. During the same quarter last year, the company earned $1.14 earnings per share. The firm's revenue was up 7.3% compared to the same quarter last year. As a group, sell-side analysts expect that Integer Holdings Co. will post 6.01 EPS for the current year.

Insider Transactions at Integer

In other Integer news, CEO Joseph W. Dziedzic sold 338,975 shares of the firm's stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $123.17, for a total value of $41,751,550.75. Following the sale, the chief executive officer now directly owns 47,000 shares in the company, valued at $5,788,990. This trade represents a 87.82% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 2.16% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on ITGR shares. Benchmark reduced their target price on shares of Integer from $150.00 to $140.00 and set a "buy" rating on the stock in a research note on Friday, April 25th. KeyCorp reduced their target price on Integer from $154.00 to $145.00 and set an "overweight" rating on the stock in a research report on Monday, April 21st. Raymond James upped their price target on Integer from $145.00 to $150.00 and gave the company an "outperform" rating in a research note on Friday, April 25th. Oppenheimer downgraded Integer from an "outperform" rating to a "market perform" rating in a research report on Friday, February 21st. Finally, Wall Street Zen raised shares of Integer from a "sell" rating to a "hold" rating in a research report on Monday, May 19th. Two analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $145.00.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.